Multiple Myeloma

A Curated Room: The People Shaping Practice

Now in its third year, this invitation-only meeting convenes a deliberately small faculty: 24 leading multiple myeloma KOLs alongside 24 hand-selected fellows and junior faculty, the clinicians defining today’s standards and the ones who will define the next decade’s, in one room for two days.

The science follows myeloma across its full course: precursor states and early intervention, MRD and risk-adapted therapy, sequencing decisions in early and late relapse, and the other plasma cell disorders often left off the program. Every session pairs expert talks with a moderated panel and a case presentation, sustained, close-quarters engagement rather than a lecture hall.